-
Boehringer Ingelheim Extends TrialScope Partnership
Jul 7, 2020, 12:05 PM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jul 7, 2020 - In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five yearsFull story -
InSysBio to announce the launch of its new tool Heta compiler
Jul 7, 2020, 05:04 AM by Michael CroftMOSCOW, RUSSIA - Jul 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platformsFull story -
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract.
Jul 6, 2020, 17:12 PM by Michael CroftGOLETA, CA, UNITED STATES - Jul 6, 2020 - FOR IMMEDIATE RELEASEFull story
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract -
Bio-IT World Announces 2020 Innovative Practices Award Winners
Jul 6, 2020, 09:00 AM by Michael CroftFull storyBio-IT World | Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance have been announced as the winners of the 2020 Innovative Practices Awards.
-
How The SARS-CoV-19 Virus Attacks Cells, Other COVID-19 News
Jul 2, 2020, 08:25 AM by Michael CroftFull storyBio-IT World | New research shows how the SARS-CoV-19 virus shifts the cell's activity to promote its own replication and to infect nearby cells. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.
-
Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
Jul 1, 2020, 11:36 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that AVIA, the nation's leading digital transformation partner for healthcare organizations, has recognized its full suite of technology solutions with AVIA Vetted and/or Market Validated designations for 2020Full story -
Saving Lives with Great Research Requires a Research Tech Rethink
Jul 1, 2020, 08:10 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Researchers are working hard to provide the evidence needed for fact-based decisions addressing everything from developing new vaccines, to ensuring existing treatments are being used to their best advantage. Now, more than ever, the time and funding allocated for these projects must be used to their fullest extent.
-
Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants
Jul 1, 2020, 03:41 AM by Michael CroftNEW YORK, NY, UNITED STATES - Jul 2, 2020 - As COVID-19 is still spreading all over the world, the global confirmed cases have jumped to 9 millionFull story -
CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations
Jul 1, 2020, 03:38 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Polyethylene glycol (PEG), a biocompatible, synthetic, hydrophilic polyether compound, is non-toxic, FDA-approved, and is frequently used in many biomedical applications including bioconjugation, drug delivery, surface functionalization, and tissue engineeringFull story -
Creative Biolabs Updated Exosome Isolation and Profiling Service to Facilitate Related Research
Jun 30, 2020, 23:11 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Recently, exosomes, which have specialized functions and play a key role in different physiological processes and pathological conditions, are attracting increasing attention in their clinical applications for prognosis, diagnosis, drug delivery, and vaccine developmentFull story -
Kyruus Achieves SOC 2 Type II Attestation
Jun 29, 2020, 11:31 AM by Michael CroftBOSTON, MA, UNITED STATES - Jun 29, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it has successfully completed its System and Organization Controls (SOC) 2 Type II examination by an independent auditorFull story -
Genomics England launches next-generation research platform central to UK COVID-19 response
Jun 29, 2020, 09:15 AM by Michael CroftLONDON, UK - Jun 29, 2020 - Genomics England (GEL) has today launched a next-generation genomic research platform that will play a key role in the research response to COVID-19Full story -
Bringing Light—and Value—to Dark Data in Research & Design
Jun 29, 2020, 08:35 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Data are often recognized as a top asset of organizations in any field, including the biosciences, but the way it’s handled may not adequately reflect this. One explanation for this mismatch is that the amount of data being produced every day is enormous—but not necessarily accessible.
-
AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers
Jun 29, 2020, 04:58 AM by Michael CroftNY, NY, UNITED STATES - Jun 23, 2020 - As an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications, the New York-based company AI & Medicine recently announces to release biomarker discovery and targeted proteomics services for researchers worldwideFull story -
Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry
Jun 29, 2020, 04:51 AM by Michael CroftNY, NY, UNITED STATES - Jun 24, 2020 - Earlier this year, Alfa Chemistry announced to have released a series of intermediates for API about flu treatment, including oseltamivir intermediates, zanamivir intermediates, and peramivir intermediates, for its valued customers both at home and abroadFull story -
Creative Enzymes Introduces Newly-Developed Enzyme Products for Some Related Projects
Jun 29, 2020, 03:56 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jun 29, 2020 - With a reputation among industrial and academic enzyme companies, Creative Enzymes has recently introduced several products for researchers working in the life science fieldFull story -
CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Genome Researchers and Projects
Jun 29, 2020, 03:49 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jun 29, 2020 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the technical escalation of its single-cell sequencing servicesFull story -
CluePoints Launches Powerful Business Intelligence Platform
Jun 26, 2020, 10:21 AM by Michael CroftKING OF PRUSSIA, PA, US - Jun 26, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new business intelligence platform, BEYONDFull story -
Calculating Herd Immunity, Other COVID-19 News and Updates
Jun 26, 2020, 08:30 AM by Michael CroftFull storyBio-IT World | Researchers are attempting to trace the emergence of COVID-19 in an effort to understand how pathogens jump from animals to humans. Meanwhile, mathematicians are developing a model estimating herd immunity. These updates, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.
-
MDI Biological Laboratory Scientist Develops New Imaging Method
Jun 25, 2020, 16:01 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jun 25, 2020 - The extraordinary progress that has been achieved in the biomedical sciences in the modern era can be attributed in large measure to imaging technologies that have allowed scientists to observe the structure and function of tissues and organs in the context of their natural tissue environments in greater detail than possible with the naked eyeFull story